8 July 2019 - The US FDA on Monday said it would prioritise and expedite the review of generic versions ...
8 July 2019 - Federal judge sides with companies, saying regulation would violate free speech. ...
8 July 2019 - All aspects of the Biotest Therapy Business Unit acquisition are successfully completed. ...
8 July 2019 - Company plans to initiate Phase 1/2 clinical trial in the second half of 2019. ...
6 July 2019 - With a drought in new blockbuster drugs, generating growth has become a challenge. ...
5 July 2019 - Three-quarters of new drugs get an expedited regulatory review, thrusting families and doctors into a new world ...
4 July 2019 - Xembify is Grifols’ first 20% subcutaneous immunoglobulin for the treatment of primary immunodeficiencies. ...
3 July 2019 - It’s one of the most seductive ideas in medicine: that “real-world evidence,” including data from electronic ...
4 July 2019 - Karyopharm Therapeutics has set a list-price for its blood cancer treatment Xpovio at $22,000 per month, ...
3 July 2019 - U.S. FDA accepts NDA for priority review. ...
3 July 2019 - INSYS Therapeutics announced today that its new drug application to the U.S. FDA for its investigational, proprietary ...
3 July 2019 - Today, the U.S. FDA granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone ...
3 July 2019 - Barely a month after Novartis won U.S. regulatory approval for its gene therapy — the most ...
3 July 2019 - It used to be that if we wanted to assess a patient’s back pain, we would evaluate ...
2 July 2019 - Personalised cell and gene therapy represent a fundamental therapeutic revolution. ...